Application Of Quality Metrics In Determining Overall State Of Quality. & The Health Of Associated PQS FDA s Current Thinking
|
|
- Marcep Inc. Training & Consulting
- 7 years ago
- Views:
Transcription
1 Course Objectives: How does industry use Metrics? FDA Challenges and equirements and Use of Quality Metrics Complexities of Implementation (Industry Feedback) What does it all mean? Key in isk identification systematic use of information to identify potential sources of harm (hazards) referring to the risk question or problem description. Enables the detection of potential problems as early as possible to plan corrective and preventive actions Provides indication that controls are losing effectiveness Important in achieving problem resolution and problem prevention Another important concept of modern quality systems is the use of trending to examine processes as a whole. Training Benefits Greater visibility and transparency between industry and regulators Ability to identify drifts earlier to drive audit/ inspection schedules isk based approach to inspections Increasing consistency of quality metrics Easy to Identifying isks Upon Completion Driving wrong behaviors and unintended consequence Establishing excessive or overly complex metrics Comparing data that is not consistently defined or comparison of single data values Using metrics as a quality surrogate Marcep Inc. is training and consulting provider for pharma sector In India. MACEP INC. train s executive s of all sectors and we do actual work so our motive behind training is to help the skills sharpening for the pharma workforce.
2 Day- One Two Day Training Modules: Day- Two Introduction to Quality Matrices What is Quality metrics Background & Glossary Modernization of egulatory Oversight of Drug Quality and Promotion of Post-Approval Improvements Use of Quality Metrics by FDA for isk-based Inspection Scheduling and Prediction of Drug Shortages Legal authority ecords Associated wie Process Validation Lifecycle and PQS Assessment Authority to Inspect ecords and equest in Advance of or In Lieu of an Inspection The Use of Quality Metrics and Effect of Non- eporting How FDA Intends to Use Quality Metrics Effect of Non-eporting Group Discussion: Implementing Trending of Quality Indices in Your Organization The importance of the right culture and people ole of leadership in trending of Quality Indices Developing an online data base for Quality Indices Analysis, interpretation and reporting of Quality Indices The Process Flow Establishing the ground rules, procedures, forms and mechanism for data collection for Quality indices Determining responsibilities and roles for the implementation of trending of Quality Indices eporting of Quality data and Calculation of Quality Metrics Who eports and Who May Contribute to the eport Quality Metrics that FDA Intends to Calculate What Quality Data Would Be eported How to eport Quality Data to FDA Instructions for Quality Metric Data Submission Worksheet for Data Tables Product Specific Information Mandatory Data Optional Metrics ecognizing and Understanding the Trending of Quality Indices Working Session I: Participants will be divided into groups and given a case study and be asked to perform a trend analysis on a given data. Each group will present the results of its analysis Working Session II: Participants will be divided into groups and given a case study and be asked to perform a trend analysis and propose a Quality metric by using isk Based approach for the specific set of data. The results of the analyses will be shared in the class. Complexities of Implementation Quality Metrics Overcoming the pitfalls Benefits and isks General Discussion and Questions Starting the Quality Indices Management Process eview of Quality Indices and Gap evaluation Preparation of Data bases for Data acquisition Collection of data for completeness and Accuracy
3 Course Director: Dr. Nishodh Saxena PhD - Chem He is a resourceful professional offering about 30 years of experience in executing Quality, egulatory Affairs, Audits & Compliance for green field projects for Pharma, Biotech plants & laboratory set up, expansion, modernization, installation & amp; commissioning of manufacturing unit. Extensive hands on experience on all Injectable/ Parenteral Dosage Forms (Prefilled syringes/ Vials/ Lyophilized Vials/ Multidose pen), Solid Dosage forms and API & intermediate manufacturing. Directly responsible for cgmp compliance and strengthening of Quality Management systems & procedures across the Organization including &D. This includes Harmonization of systems & procedures, cgmp compliance, Corporate audits, Training, Audit and compliance, design and execution, layout design and detailed engineering, validation of facility, water system, equipment, method, process, cleaning validation, computer and electronic system validation, change control, deviation, OOS, OOT, investigation, CAPA, maintenance and preventive maintenance, stability testing, quality control, batch control and product release, media fill trials, documentation system, product recalls, internal quality audit- self inspection, complaint handling, risk analysis, APQ, EM and water quality monitoring, cold chain and shipper validation, Vendor qualification, implementation of IT systems like SAP, EP, LIMS and electronic documentation, knowledge sharing, designing of system according to various country specific regulatory guidelines, including egulatory updates, support for egulatory audits etc. for Manufacturing sites. Have successfully faced several USFDA, MHA, TGA, WHO-Geneva, ANVISA, audits and other MOH audits. Involved in Projects with respect to Quality assurance and automation in QMS. Extensive experience in developing and managing cross functional and multi- location teams/ activities encompassing outsourced manufacturing, in- process QA, technology transfers and compliance to integrated cgmp/ cglp standards and setting up cost effective quality monitoring systems. Ensuring that teams adhere to robust quality standards & procedures through precision/ calibration and monitoring sessions. An out of the box thinker with exceptional track record that demonstrates self- motivation, creativity, and initiative to achieve corporate goals through interpersonal skills and team spirit. Notable Accomplishments: First- hand experience in negotiating with US FDA, CHMP and MHA. Author of Monographs for Indian and European Pharmacopoeia. Played a key role in installation new Analytical, Process Control and QA laboratories through capacity calculation, design, budgeting, and procurement. International speaker on Quality, egulatory & isk Mgmt. aspects of pharma sector. Having a work experience for Indian Pharma Giants: Jubilant Life Sciences Ltd. OmniActives Health Technologies Ltd. Pune USV Ltd. ZydusCadila Healthcare Ltd, Ahmedabad Intas Pharmaceuticals Ltd., Ahmedabad Dr. eddy's Lab Ltd., B. V. Patel (PED) Center, Ahmedabad Nixcil Pharmaceutical Specialties Limited, Lucknow Ph.D. (Chemistry) from Central Drug esearch Institute, Lucknow
4 Delegate egistration Form: Please register the following delegate/s for (For Additional delegates please photocopy this form) PATICIPATION DETAILS Name: Designation: Location: Organisation Details & Authorization: I / We Hereby Confirm To The Above And Authorize Our Participants To The Programme. Please Send The Invoice To: Company Name: Nominating Authority: Designation: Company Postal Address: Tel No.: Cell No.: * This Booking is Invalid Without Signature Signature Investment fees 01 Delegate - IN: 24,500/- (Base Price) Additional service tax of 15% is applicable Sales Hotline No.: or taniya@marcepinc.com Payment Terms: Payment Is equired Within 5 Working Days From the Date Of Invoice. Account Transfer/Cheque/DD Should Be In Favour Of Marcep Inc. Payable At Par In. NON- ESIDENTIAL POGAME Participation Fees Include: Workshop kit Documentation, efreshment, Luncheon, Certificate Of Participation For group nomination queries reply on: info@marcepinc.com Marcep Inc. Terms and Conditions Payment terms - Upon completion and return of the registration form, full payment is required not later than 5 business days from the date of invoice. Payment must be received prior to the event date. Marcep Inc. reserves the right to refuse admission to the event if payment has not been received. Cancellation, postponement and substitution policy - You may substitute delegates at any time by providing reasonable advance notice to Marcep Inc. In the event that Marcep Inc. postpones an event for any reason and the delegate is unable to attend on the revised date, you will receive full credit of the contract fee paid. On mutual agreement, you may use this credit for another Marcep Inc. event which must occur within one year from the date of postponement. Except as specified above, no credits will be issued for cancellations. There are no refunds given under any circumstances. Marcep Inc. is not responsible for any loss or damage as a result of a substitution, alteration or cancellation/ postponement of an event. Marcep Inc. will not take any liability whatsoever if the event is cancelled, rescheduled or postponed due to act of God, natural calamities or any other emergencies. Please note that while course speakers and topics were confirmed at the time of marketing, for circumstances beyond our control, the organization reserves the right to substitute, alter or cancel the speakers and/or topics Marcep Inc. reserves the right to alter or modify the speakers and/or topics if necessary without any liability to you what so ever. Updates on any substitutions or alterations will be provided as soon as possible. Discounts All 'Early Bird' Discounts require payment at time of registration and before the cut-off date in order to receive any discount. Offered discounts by Marcep Inc. (including team discounts) must also require payment at the time of registration. All discount offers will stand cancelled if payment is not received at the time of registration. Marcep Inc. Campz Landmark Bldg., 103, 1st floor, Next to Tata Motors Showroom, S.V. oad, Jogeshwari- West, Tel: Fax: info@marcepinc.com
GAMP 5 & 21 CFR Part 11 Compliance With Computer System Validation
Course Objectives: GAMP 5 & Computer System Validation issues are like Diabetes it is not hard to controlled by better life style. If not controlled it can be source of many diseases when combined with
More informationQuality Metrics An FDA Perspective PDA Dinner and Dialogue. Melissa Seymour VP, Corporate Quality DRAFT
Quality Metrics An FDA Perspective PDA Dinner and Dialogue Melissa Seymour VP, Corporate Quality DRAFT Agenda How does industry use Metrics? FDA Challenges and Requirements and Use Complexities of Implementation
More information2010 Critical Thinker Series
Malaysian Organisation of Pharmaceutical Industries (MOPI) & PharmEng Technology Presents cgmp Case Studies a T rra ini ing i P rrog rram ffo rr cgmp P rro ffe ss ss ionai l ss 2010 Critical Thinker Series
More informationA NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry PROJECT MANAGEMENT: RENOVATION OF RESEARCH LABORATORY FOR CELL CULTURE
More informationA NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry CLEANING VALIDATION Instructors Loh Kean Chong Rick Ng Date and Time
More informationICH Q7 GMP for Active Pharmaceutical Ingredients
National University of Singapore Academy of GxP Excellence (NUSAGE) and PharmEng Technology Presents ICH Q7 GMP for Active Pharmaceutical Ingredients Part of the Pharmaceutical Biotechnology Training Courses
More informationICH Q10 Pharmaceutical Quality System (PQS)
ICH Q10 Pharmaceutical Quality System (PQS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Q10 PQS Guideline Background Objectives
More informationPHARMACEUTICAL QUALITY SYSTEM Q10
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL QUALITY SYSTEM Q10 Current Step
More informationAddressing Risk in Partner / Contractor Selection and Onboarding. Michael Davidson VP Quality Systems and Compliance March 2014
Addressing Risk in Partner / Contractor Selection and Onboarding Michael Davidson VP Quality Systems and Compliance March 2014 Industry Trends Pfizer Overview Pfizer s Approach Risk Based Robust Due Diligence
More informationGuidance for Industry. Q10 Pharmaceutical Quality System
Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation
More informationPharmaceutical Quality Management System: Current Concept
Pharmaceutical Quality Management System: Current Concept Neetu Dubey 1, *, Himanshu Gupta 3, R.K. Sharma 2, Nitin Dubey 1, Nidhi Dubey 4 1. IPS Academy, Indore, Madhya Pradesh, India. 2. Prestige Institute
More informationGMP Pharma BV. Netherlands
GMP Pharma BV Netherlands Connecting the European & Indian Pharmaceutical, Biotechnology and Biopharmaceutical Industry for parallel growth and solicitation. About Us: GMP Pharma BV is a multisource organization
More informationIntroduction to Q10 Pharmaceutical Quality System
ICH-GCG Asean Training Workshop on ICH Guidelines Q8,Q9 and Q10 (New Paradigm) Introduction to Q10 Pharmaceutical Quality System Georges FRANCE, Q- IWG Kuala Lumpur, Malaysia 26-28 July 2010 International
More informationICH Q 10 Pharmaceutical Quality System PQS DIA China Annual Meeting, May 2010
ICH Q 10 Pharmaceutical Quality System PQS DIA China Annual Meeting, May 2010 Joseph C. Famulare Head of External Relations and Collaboration Pharma Global Technical Operations Global Quality, F. Hoffmann-La
More informationICH guideline Q10 on pharmaceutical quality system
September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final
More informationLibrary Guide: Pharmaceutical GMPs
Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA
More informationRequest for Quality Metrics Guidance for Industry
Request for Quality Metrics Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document should be
More informationBest Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants
Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants Alex D. Kanarek, PhD BioProcess Technology Consultants, Inc. Strategic Institute Quality
More informationProduct Complaints Management. Infosys Handbook for Life Sciences
Product Complaints Management Infosys Handbook for Life Sciences Table of Contents Introduction 3 Infosys Point of View 4 Success Story - Complaint management for one of the world s top 5 bio-pharmaceutical
More informationQuality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:
NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a
More informationICH Q10 - Pharmaceutical Quality System
WCC PDA Dinner Meeting Jan 2012 ICH Q10 - Pharmaceutical Quality System Neil Wilkinson NSF-DBA www.nsf-dba.com ICHQ10.1 WCC PDA Dinner Meeting Jan 2012 Your Presenter Partner at NSF-DBA USA Training, Consultancy,
More informationBest Practice In A Change Management System
Quality & Compliance Associates, LLC Best Practice In A Change Management System President Quality & Compliance Associates, LLC Change Control and Its Role in a Continuous Improvement Environment 3 Benefits
More informationNew Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01)
Safeguarding public health New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01) Tony Orme, Senior GDP Inspector Inspection, Enforcement and Standards Division
More informationComputerised Systems in Analytical Laboratories
ECA Certified Computer Validation Manager Course* New EU Annex 11 and Chapter 4 Requirements will be covered Computerised Systems in Analytical Laboratories Foto: DRK The Electronic Analytical GMP : Integrating
More informationSTREAMLINE HR BUSINESS PARTNERING & STRATEGY DEVELOPMENT
STREAMLINE HR BUSINESS PARTNERING & STRATEGY DEVELOPMENT CAPITALIZE ON EXPERT KNOWLEDGE TO GAIN MAXIMUM VALUE ON THESE VITAL ISSUES Understand the basic questions you need to consider when developing an
More informationOOS investigations in a GMP environment
PharmaTraining and PMcG Consulting present - OOS investigations in a GMP environment 17 & 18 October 2016 UK Course objectives This course is designed to provide essential training for conducting Out of
More informationConducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.
Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management
More informationProcess Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation)
Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation) Los Angeles, CA July 28th & 29th, 2016
More informationWorking with ICH Quality Guidelines - the Canadian Perspective
Working with ICH Quality Guidelines the Canadian Perspective Krishnan Tirunellai, Ph. D. Bureau of Pharmaceutical Sciences Therapeutic Products Directorate Health Canada December 3, 2008 Outline Introduction
More informationGMP Facility Design with Good Engineering Practice
National University of Singapore Academy of GxP Excellence (NUSAGE) and PharmEng Technology Presents GMP Facility Design with Good Engineering Practice Part of the Pharmaceutical and Biotechnology Training
More informationData Governance Planning PDA 12 May 2015
Data Governance Planning PDA 12 May 2015 1 Agenda Overview of Data Integrity Assurance of Data Data Governance The Data Governance Plan Questions 2 Overview of Data Integrity 3 Data Information derived
More informationEstablish Collaborative Strategies to Better Manage a Global Vendor Network Devise a Proper Float Plan
Establish Collaborative Strategies to Better Manage a Global Vendor Network Devise a Proper Float Plan CBI s Biopharmaceutical Forum on Clinical and Commercial Global Supply Chain Excellence Sandy Onorato
More informationASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE
ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE THIS POLICY OUTLINES THE TOP LEVEL REQUIREMENTS TO SUPPORT PRODUCT QUALITY IN THE DEVELOPMENT, MANUFACTURE AND DISTRIBUTION OF ACTIVE PHARMACEUTICAL
More informationQuality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers
Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers integrating GMP (ICH Q7a) into ISO (9001: 2000) September 2005 Quality Management System - integrating GMP (ICH
More informationPROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)
January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal
More informationTitle:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions
WELCOME Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions Contents: Introduction GMP Audit GMP Audit plan GMP Auditing
More informationGOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme
GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme Contents 1. Why good documentation is essential? 2. What constitutes
More informationCombination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma
Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)
More informationGuidance for Industry
Guidance for Industry Q8, Q9, and Q10 Questions and Answers(R4) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics
More informationTaking a Leap Toward Global Supply Chain Efficiency
Taking a Leap Toward Global Supply Chain Efficiency 2 Taking a Leap Toward Global Supply Chain Efficiency INTRODUCTION PROBLEM STATEMENT Pharmaceutical manufacturers face a number of challenges to produce
More informationStep-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry
Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry BY GHULAM A. SHABIR Introduction Methods Validation: Establishing documented evidence that provides a high
More informationAuditing as a Component of a Pharmaceutical Quality System
Auditing as a Component of a Pharmaceutical Quality System Tim Fields Conducting internal audits (or self inspections) and external audits of suppliers and outsourcing operations are key elements of a
More informationSupply Chain Challenges and Risk Management
Supply Chain Challenges and Risk Management Presented by Steve Williams Director SeerPharma P/L 21 st April 2009 PDA April 09 SW 1 Supply Chain - Some Useful Guidance cgmp Annex 8 cgmp Chapter 7 ICH Q7
More informationTalent Management & Succession Planning Masterclass
Talent Management & Succession Planning Masterclass The Capital 20 West Hotel, Johannesburg, South Africa 24 27 March 2015 WHAT YOU WILL ACHIEVE: Increase your working knowledge and your ability to manage
More information3rd ANNUAL SEMINAR PHARMASSIST Ltd in collaboration with PHARMA D&S Srl
Venue: To be announced 3rd ANNUAL SEMINAR Quality Risk Management & Quality Risk Management (ICH Q9) & Applications in the Pharmaceutical Quality System (ICH Q10): Applications in the Pharmaceutical Sector
More informationElectronic GMP Systems
Electronic GMP Systems Specification - Implementation Validation 18 20 March 2015, Prague, Czech Republic SPEAKERS: Kai Kiefer fme AG, Germany Dr Bob McDowall McDowall Consulting, UK LEARNING OBJECTIVES:
More informationChanges to an Approved Product
Changes to an Approved Product Chemistry, Manufacturing and Controls By Khandan Baradaran, PhD and Peggy Berry, MBA, RAC It is a huge achievement for any company to obtain licensing rights to an approved
More informationLean Strategies for Laboratory Testing
Microrite, Inc. brings you this unique learning experience in Lean Strategies for Laboratory Testing; Part of Microrite s step-by-step webinar series. Lean Strategies for Laboratory Testing erience in
More information20-21 May 2015, Lisbon, Portugal. Highlights. Speakers:
Speakers: Dr Afshin Hosseiny Chair of the ECA Expert Working Group on GDP, Tabriz Consulting Comply with the new EU GDP Guideline Dr Martin Egger Pharmaserv Dr Daniel Müller GMP/GDP Inspector All participants
More informationInternational GMP Requirements for Quality Control Laboratories and Recomendations for Implementation
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. ludwig_huber@labcompliance.com Overview GMP requirements for Quality Control laboratories
More informationMANAGING THE COMPLEXITIES OF GLOBAL PHARMACEUTICAL SOURCING
DPT Thought Leadership Issue 10 MANAGING THE COMPLEXITIES OF GLOBAL PHARMACEUTICAL SOURCING With the increased globalization and complexity of the pharmaceutical supply chain, managing the sourcing of
More informationADVANCED BUDGET MANAGEMENT PROGRAM
ADVANCED BUDGETMANAGEMENT PROGRAM AccreditedbyInstituteofCertifiedManagementAccountant Philippines ForInquiriespleasecall (+632)6879856oremailat ADVANCED BUDGET MANAGEMENT PROGRAM This is an advanced interactive
More informationPharmaceutical Quality Systems: US Perspective
Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical
More informationUniversity Accredited National Programme 2012 - Training Matters in Dementia Care
University Accredited National Programme 2012 Diploma Level: Training Matters in Dementia Care. Benefit from: Learning and practising how to deliver dementia care training that really matters. Shifting
More informationThe Paperless QMS March 2012
The Paperless QMS March 2012 Overview Introductions What do we mean by Paperless QMS? Short history of the (pharma) Paperless QMS What do you need your Paperless QMS to do? Practical application and considerations
More informationRutgers Mini-MBA : BioPharma Innovation
Rutgers Mini-MBA : BioPharma Innovation Ga i n t h e s k i l l s to t r a n s f o r m scientific i n n ovat i o n i n to business success www.cmd.rutgers.edu/innovation Rutgers Mini-MBA : BioPharma Innovation
More informationGuidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations
Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)
More informationSUPPLY CHAIN MANAGEMENT PROFESSIONAL CERTIFICATION BY CII. CII - SCM Pro
SUPPLY CHAIN MANAGEMENT PROFESSIONAL CERTIFICATION BY CII CII - SCM Pro 1. Eligibility: Bachelor s degree with relevant work experience of 3 years or B.E/B.Tech/MBA/ME/M.Tech with 2+yrs of work experience
More informationOptimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy
Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy Global Pharma Sourcing Conference December 6-7, 2011 Philadelphia, USA Nigel J. Smart, Ph.D. Smart Consulting
More informationQuality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle
Quality Risk Management 11 November 2011 Galway, Ireland Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle Overview Regulatory
More informationQuality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation
Quality Assurance Disclosure for Lilli Møller Andersen No relevant financial relationships exist for any issue mentioned in this presentation Agenda Quality Assurance Quality Management System Quality
More information100 HOT TOPICS FOR DISSERTATION FOR PG DIPLOMA/ DEGREE IN REGULATORY AFFAIRS
100 HOT TOPICS FOR DISSERTATION FOR PG DIPLOMA/ DEGREE IN REGULATORY AFFAIRS Mr. R.M. Gupta (M. Pharm.), is a free lancer consultant for US DMF, COS, ANDA, ACTD, CTD, ectd and he is also the director of
More information2 Day Seminar Assuring Data Integrity in the Life Science industry
2 Day Seminar Assuring Data Integrity in the Life Science industry Location 1: Boston Sep 08 09 Hilton Garden Inn Boston Logan Airport 100 Boardman Street, Boston, MA 02128 Hotel: 617-567- 6789 Location
More informationMODA Solution Automated QC Microbiology Processes for Regulated Manufacturing
Pharma&Biotech MODA Solution Automated QC Microbiology Processes for Regulated Manufacturing Informatics for Rapid Testing Pharma&Biotech MODA TM Solution Informatics for Rapid Testing «Eliminate unnecessary
More informationAligning Quality Management Processes to Compliance Goals
Aligning Quality Management Processes to Compliance Goals MetricStream.com Smart Consulting Group Joint Webinar February 23 rd 2012 Nigel J. Smart, Ph.D. Smart Consulting Group 20 E. Market Street West
More informationGRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors
GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors This course is a distance-learning program that will culminate in a Graduate
More informationValidation Consultant
Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 172 737 84 86 E-Mail: Internet: jsb-val@online.de http://www.jsb-validierung.de
More informationPharmaceutical Wholesaler Site Inspection Checklist
Pharmaceutical Wholesaler Site Inspection Checklist Date and time of inspection: Legal business name and plant name: Location (address): Phone number: Fax number: Email address: Web site URL: Contact Person:
More information2016 > Emcure Pharmaceuticals Limited 3/3/16
Seite 1 von 7 U.S. Food and Drug Administration Protecting and Promoting Your Health Emcure Pharmaceuticals Limited 3/3/16 Department of Health and Human Services Public Health Service Food and Drug Administration
More informationThe Board reviews risks to the Company s business plan at its scheduled meetings.
Pharmaxis Ltd 1. Board responsibility The Pharmaxis Board is responsible for ensuring the Company establishes and maintains a risk management framework for the oversight and management of risk. The Board
More informationPHARMACEUTICAL OUTSOURCING:
PHARMACEUTICAL OUTSOURCING: QUALITY MANAGEMENT AND PROJECT DELIVERY Trevor Deeks, Karen Ginsbury and Susan Schniepp Editors CONTENTS Preface 1 OVERVIEW OF OUTSOURCED OPERATIONS Susan Schniepp 2 LEGAL ASPECTS
More informationLet s skip over the next ten
FOCUS ON... COMPLIANCE Risk-Based Quality Management Systems What Are We Waiting For? by Carol DeSain Let s skip over the next ten years, the changes in FDA policy, politics and leadership; the age-old
More informationGuidance for Industry Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products
Guidance for Industry Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products U.S. Department of Health and Human Services Food and Drug Administration
More informationA Stability Program for the Distribution of Drug Products
A Stability Program for the Distribution of Drug Products Teresa I. Lucas*, Rafik H. Bishara, and Robert H. Seevers Drug products must be transported in a manner that ensures products will be maintained
More informationHarmonizing Change Control Processes Globally
Quality & Compliance Associates, LLC Harmonizing Change Control Processes Globally President Quality & Compliance Associates, LLC When We Deal In A Global Environment, How Do We Design A System That Addresses
More informationComparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE
Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance
More informationProduct Liability Risk Control Checklist
Product Liability Risk Control Checklist Appendix C1 This material will help you evaluate your products liability exposure. It is designed to enable you to focus on areas that need to be addressed to safeguard
More informationValidation Approach and Scope for Business Process System Validation. Epitome Technologies Private Limited
Validation Approach and Scope for Business Validation Epitome Technologies Private Limited PROPOSAL Page 2 of 8 Table Of Contents: 1.0 GENERAL... 3 2.0 SCOPE MODULES COVERED... 3 3.0 QUALIFICATION APPROACH...
More informationAnnex 7 Guidelines for the preparation of a contract research organization master file
World Health Organization WHO Technical Report Series, No. 957, 2010 Annex 7 Guidelines for the preparation of a contract research organization master file Background 1. General information 2. Quality
More informationCOMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance
More informationCALCET Company California Consulting Engineering & Technology 14895 E14th St. Ste 340, San Leandro, CA 94578 USA www.calcet.com
CALCET Company California Consulting Engineering & Technology 14895 E14th St. Ste 340, San Leandro, CA 94578 USA www.calcet.com ENGINEERING A PIVOTAL ROLE IN BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES
More informationWorking Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice
Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 S\common\legal-legislation\75-319nd81-851\91-356\eudralexvol4\Annex
More information2016 LEARNING AND DEVELOPMENT PROGRAMMES NIM ABUJA MANAGEMENT CENTRE
2016 LEARNING AND DEVELOPMENT PROGRAMMES NIM MANAGEMENT CENTRE FINANCE AND ACCOUNTING MANAGEMENT COURSE S/N. COURSE TITLE DATES/LOCATION 1. Financial and Managerial Accounting Fundamentals for Non-Financial
More information1 The quality management system (QMS) is the corner stone of compliance to GMP. The QMS is made up of several documents, that when followed ensures the GMP compliance of the process, facility and company.
More informationASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 038-1 26 March 2012 AIDE-MEMOIRE ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PIC/S March 2012 Reproduction
More informationRegulatory Asset Management: Harmonizing Calibration, Maintenance & Validation Systems
Regulatory Asset Management: Harmonizing Calibration, Maintenance & Validation Systems 800.982.2388 1 Introduction Calibration, maintenance and validation activity, despite operating within the same department
More informationAuditing Chromatographic Electronic Data. Jennifer Bravo, M.S. QA Manager Agilux Laboratories
Auditing Chromatographic Electronic Data Jennifer Bravo, M.S. QA Manager Agilux Laboratories Outline Raw data paper or electronic record? Controls for electronic data Auditing electronic records Warning
More informationEnsuring Quality Going Down the Supply Chain
Ensuring Quality Going Down the Supply Chain (Including Vendor Qualification) What is the Role of Operators, Vendors and Regulators? April 21, 2015 DAE-HEE LEE Contents Nuclear Quality Issues The Role
More informationGuideline on good pharmacovigilance practices (GVP)
1 2 20 February 2012 EMA/541760/2011 3 4 Guideline on good pharmacovigilance practices (GVP) Module I Pharmacovigilance systems and their quality systems Draft finalised by the Agency in collaboration
More informationBrand Quality with Asian Advantages
Brand Quality with Asian Advantages ScinoPharm Taiwan, Ltd. No.1, Nan-Ke 8th Road, Tainan Science Park, Shan-Hua, Tainan, 74144, Taiwan TEL : 886-6-505-2888 FAX : 886-6-505-2898 Email Contact : mkt@scinopharm.com
More informationCorrective and Preventive Actions
Corrective and Preventive Actions A Five Step Approach Topics to Be Covered What is CAPA? Governing authority Five steps to a good CAPA process Where companies have difficulty Example citations Recap What
More informationChapter 2 INDUSTRIAL BUYING BEHAVIOUR: DECISION MAKING IN PURCHASING
Chapter 1 THE ROLE OF PURCHASING IN THE VALUE CHAIN The role and importance of the purchasing and supply function in the value chain. The difference between concepts such as ordering, buying, purchasing,
More informationCommercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations
Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical
More informationValidation and Part 11/Annex 11 Compliance of Computer Systems
Validation and Part 11/Annex 11 Compliance of Computer Systems by Dr. Ludwig Huber 05 & 06 June 2013, Elite World Hotels, Istanbul - TURKEY Why to attend Computer systems should be validated to demonstrate
More information11 MEDICATION MANAGEMENT
1 11 MEDICATION MANAGEMENT OVERVIEW OF MEDICATION MANAGEMENT Depending on the size, structure and functions of the health facility, there may be a pharmacy with qualified pharmacists to dispense medication,
More informationTrack & Trace. The Distribution Chain to the EU and within the EU
ECA ACADEMY The new GDP and Track & Trace Regulations in Europe Jersey City, NJ (New York City Metro Area), USA July 14-15, 2015 A conference organised by the ECA Academy and the European QP Association
More informationThe Quality System for Drugs in Germany
The Quality System for Drugs in Germany Prof. Dr. Harald G. Schweim Head of Department for Drug Regulatory Affairs Institute for Pharmacy, University of Bonn Former President of the German Federal Institute
More informationProject Finance in the Oil and Gas Industry
Book early and SAVE 10% www.clariontraining.com/energy A three-day practical applied training course for Oil and Gas Industry Professionals Get to grips with financial and economic techniques, sources
More informationCROSS CULTURAL COMMUNICATION Developing a Global Mindset Developing Cross & Bridging the Cultural Gap between Cultures
CROSS CULTURAL COMMUNICATION Developing a Global Mindset Developing Cross & Bridging the Cultural Gap between Cultures OVERVIEW 4-5 November 2014, Armada Petaling Jaya *Checkout the latest dates and training
More informationQUALITY RISK MANAGEMENT (QRM): A REVIEW
Lotlikar et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), 149-154 149 Available online at http://jddtonline.info REVIEW ARTICLE QUALITY RISK MANAGEMENT (QRM): A REVIEW Lotlikar MV Head Corporate
More information